EI
APLT

EAM Investors’s Applied Therapeutics APLT Stock Holding History

EAM Investors’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-92,872
Closed -$632K – 252
2024
Q1 		$632K Sell
92,872
-89,998
-49% -$404K 0.1% 222
2023
Q4 		$613K Sell
182,870
-208,725
-53% -$519K 0.11% 213
2023
Q3 		$975K Buy
+391,595
New +$645K 0.19% 246

Other funds holding APLT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EAM Investors's APLT Position: Q2 2024 in Review

EAM Investors sold out of Applied Therapeutics (APLT) in Q2 2024, closing a stake of 92,872 shares — an estimated $632K sold.

EAM Investors first reported a position in APLT in Q3 2023 and held it in 3 quarters. The position peaked at $975K in Q3 2023. 94 funds tracked by Wall St. Rank hold APLT as of Q2 2024.

  • EAM Investors reported no remaining Applied Therapeutics position as of Q2 2024 after selling out during the quarter.
  • EAM Investors sold 92,872 Applied Therapeutics shares in Q2 2024, an estimated $632K.
  • EAM Investors first reported a position in Applied Therapeutics in Q3 2023 and held it in 3 quarters.
  • EAM Investors's Applied Therapeutics position peaked at $975K in Q3 2023.
  • 94 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2024.

Based on EAM Investors's 13F filing for Q2 2024, filed 12 Aug 2024.